作者: Elias Toubi , Amos Etzioni
关键词:
摘要: Intravenous immunoglobulin (IVIg) has been used successfully for hypogamma-globulinemic states more than 20 yr. In both primary and secondary situations when hypogammaglobulinemia is of clinical significance, IVIg should be the first line treatment. most cases, 400 mg/kg infused every 3 to 4 wk will lead a trough level higher 500 mg/dL, which in cases provides good protection against bacterial infections. Higher doses may needed patients with known lung damage.